Circulatory YKL-40 & NLR: Underestimated Prognostic Indicators in Diffuse Glioma
Open Access
- 1 March 2018
- journal article
- research article
- Vol. 7 (2), 111-118
- https://doi.org/10.22088/IJMCM.BUMS.7.2.111
Abstract
In addition to histopathological parameters, evaluation of associated hematological factors is essential for devising a sensitive prognostic scale in glioma. Increased neutrophil-lymphocyte ratio (NLR), a marker of systemic inflammatory response, has recently been associated with worse outcome in various cancers. Given that glioma progression is characterized by inflammation, aggressive angiogenesis, and invasion, ...Keywords
This publication has 24 references indexed in Scilit:
- Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-AnalysisCancer Epidemiology, Biomarkers & Prevention, 2014
- Apoptosis-related gene expression in glioblastoma (LN-18) and medulloblastoma (Daoy) cell linesHuman Cell, 2013
- Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomasNeuro-Oncology, 2011
- Role of YKL-40 in the Angiogenesis, Radioresistance, and Progression of GlioblastomaOnline Journal of Public Health Informatics, 2011
- Role of Chitin and Chitinase/Chitinase-Like Proteins in Inflammation, Tissue Remodeling, and InjuryAnnual Review of Physiology, 2011
- Resveratrol represses YKL-40 expression in human glioma U87 cellsBMC Cancer, 2010
- Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 Genes Involved in the Double-Strand Break Repair Pathway Predict Glioblastoma SurvivalJournal of Clinical Oncology, 2010
- YKL-40 is directly produced by tumor cells and is inversely linked to EGFR in glioblastomas.2010
- Serum YKL-40, A New Prognostic Biomarker in Cancer Patients?Cancer Epidemiology, Biomarkers & Prevention, 2006
- The Hallmarks of CancerCell, 2000